SKAN Group AG (SWX: SKAN)
Health Care · Life Sciences Tools & Services · CH
CHF70.30
-0.99% today · +24.3% 1Y
SKAN Group AG (SWX: SKAN) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $1.91B and employs 1,694 people.
Over the last twelve months the share price has gained 24.3%, trading between 35.75 and 70.70.
Tweenvest scores SKAN Group AG across four factors: quality 76/100, value 43/100, growth 83/100, dividend 11/100. Its strongest factor is growth.
SKAN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.91B
- Revenue (TTM)
- $449.57M
- P/E
- 53.24
- EPS
- 1.33
- Dividend yield
- 0.31%
- Beta (5Y)
- 0.75
- 52-week high
- CHF70.70
- 52-week low
- CHF35.75
- Avg volume (3M)
- —
- Shares outstanding
- 22.48M
- Employees
- 1,694
- Next earnings
- —
About SKAN Group AG
SKAN Group AG is a global leader specializing in critical solutions for the pharmaceutical and chemical sectors, offering advanced isolators, cleanroom technologies, and decontamination processes across Asia, Europe, and the Americas. The company operates through two distinct divisions: Equipment and Solutions (E&S), and Services and Consumables (S&C). Its E&S segment delivers essential products for pharmaceutical manufacturing, including high-tech isolators, integrated automated systems, aseptic filling solutions, and specialized laboratory and cleanroom equipment. Meanwhile, the S&C segment focuses on providing comprehensive life cycle support, ready-to-use consumables, and custom digital and client-specific solutions. Founded in 1968, the company, which changed its name from BV Holding AG to SKAN Group AG in October 2021, is headquartered in Allschwil, Switzerland.
- ISIN
- CH0013396012
- Founded
- 1968
- Listed since
- Dec 28, 2021
- Exchange
- SIX Swiss Exchange
- Currency
- CHF
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shanghai InnoStar Bio-tech Co., Ltd.SHSE: 688710 | $2.21B | CN¥105.20 | +9.58% |
| Shanghai Medicilon Inc.SHSE: 688202 | $2.11B | CN¥107.64 | +3.54% |
| AddLife AB (publ)OM: ALIF B | $2.08B | Skr170.60 | -0.41% |
| Fortrea Holdings Inc.NasdaqGS: FTRE | $1.96B | $20.37 | -0.92% |
| Suzhou Sepax Technologies Co., Ltd.SHSE: 688758 | $1.87B | CN¥30.13 | -7.29% |
| BioLife Solutions, Inc.NasdaqCM: BLFS | $1.82B | $38.61 | +3.51% |
| OneSource Specialty Pharma LimitedNSEI: ONESOURCE | $1.80B | Rs1,508.00 | -5.90% |
| PolyPeptide Group AGSWX: PPGN | $1.76B | CHF43.90 | -0.45% |
Figures last refreshed Oct 4, 2026.